Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Tuesday, 11 January 2022

Psychedelic Stock News: Awakn Life Sciences (OTCQB: AWKNF) Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

Psychedelic Stock News: Awakn Life Sciences (OTCQB: AWKNF) Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

No comments:

Post a Comment

Cannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Restates Q1 Financial Statements to Meet PCAOB Standard

Cannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Restates Q1 Financial Statements to Meet PCAOB Standard